These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2520752)

  • 21. Conformation of parathyroid hormone antagonists by CD, NMR, and molecular dynamics simulations.
    Chorev M; Behar V; Yang Q; Rosenblatt M; Mammi S; Maretto S; Pellegrini M; Peggion E
    Biopolymers; 1995 Oct; 36(4):485-95. PubMed ID: 7578943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parathyroid hormone-related protein and hypercalcaemia of malignancy.
    Ratcliffe WA
    J Pathol; 1994 Jun; 173(2):79-80. PubMed ID: 8089809
    [No Abstract]   [Full Text] [Related]  

  • 23. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
    Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
    Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Humoral hypercalcemia in neoplasias: role of parathyroid hormone related peptide (PTH-rp)].
    Gardin JP; Paillard M
    Rev Prat; 1991 Feb; 41(4):347-9. PubMed ID: 2008586
    [No Abstract]   [Full Text] [Related]  

  • 25. Pathobiology of parathyroid hormone and parathyroid hormone-related protein: introduction and evolving concepts.
    Capen CC; Rosol TJ
    Monogr Pathol; 1993; (35):1-33. PubMed ID: 8502246
    [No Abstract]   [Full Text] [Related]  

  • 26. Parathyroid hormone-related protein in pancreatic exocrine cancer associated with hypercalcaemia.
    Bandyopadhyay P; Baksi S; Bandyopadhyay D; Patel CU
    Int J Clin Pract; 2003 Mar; 57(2):140-2. PubMed ID: 12661799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humoral hypercalcemia of malignancy.
    Burtis WJ; Wu TL; Insogna KL; Stewart AF
    Ann Intern Med; 1988 Mar; 108(3):454-7. PubMed ID: 3277518
    [No Abstract]   [Full Text] [Related]  

  • 28. Parathyroid hormone-related peptide in hypercalcemia associated with adult T cell leukemia/lymphoma: molecular and cellular mechanism of parathyroid hormone-related peptide overexpression in HTLV-I-infected T cells.
    Ikeda K; Inoue D; Okazaki R; Kikuchi T; Ogata E; Matsumoto T
    Miner Electrolyte Metab; 1995; 21(1-3):166-70. PubMed ID: 7565442
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of postreceptor effects of 1-34 human hypercalcemia factor and 1-34 human parathyroid hormone in rat osteosarcoma cells.
    Rodan SB; Noda M; Wesolowski G; Rosenblatt M; Rodan GA
    J Clin Invest; 1988 Mar; 81(3):924-7. PubMed ID: 2830317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformational studies of parathyroid hormone (PTH)/PTH-related protein (PTHrp) chimeric peptides.
    Schievano E; Mammi S; Silvestri L; Behar V; Rosenblatt M; Chorev M; Peggion E
    Biopolymers; 2000 Nov; 54(6):429-47. PubMed ID: 10951329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties of parathyroid hormone-related protein and its role in malignant hypercalcaemia.
    Martin TJ
    Q J Med; 1990 Aug; 76(280):771-86. PubMed ID: 2217682
    [No Abstract]   [Full Text] [Related]  

  • 32. A synthetic 15-mer peptide (PCK3145) derived from prostate secretory protein can reduce tumor growth, experimental skeletal metastases, and malignancy-associated hypercalcemia.
    Shukeir N; Arakelian A; Chen G; Garde S; Ruiz M; Panchal C; Rabbani SA
    Cancer Res; 2004 Aug; 64(15):5370-7. PubMed ID: 15289344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humoral hypercalcemia of malignancy in squamous cell carcinoma of the skin: parathyroid hormone--related protein as a cause.
    Cisneros G; Lara LF; Crock R; Whittier FC
    South Med J; 2001 Mar; 94(3):329-31. PubMed ID: 11284521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Parathyroid hormone-related peptide induced humoral hypercalcemia of malignancy].
    Tfelt-Hansen J; Brixen KT; Mosekilde L; Schwarz P
    Ugeskr Laeger; 2005 Feb; 167(8):924-6. PubMed ID: 15789851
    [No Abstract]   [Full Text] [Related]  

  • 35. [Humoral bone resorbing factor(s) produced by cancer].
    Nagata N
    Rinsho Byori; 1988 Dec; 36(12):1393-8. PubMed ID: 3249401
    [No Abstract]   [Full Text] [Related]  

  • 36. NMR solution structure of the [Ala26]parathyroid-hormone-related protein(1-34) expressed in humoral hypercalcemia of malignancy.
    Ray FR; Barden JA; Kemp BE
    Eur J Biochem; 1993 Jan; 211(1-2):205-11. PubMed ID: 8425530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo models of hypercalcemia of malignancy.
    Schilling T
    Recent Results Cancer Res; 1994; 137():44-75. PubMed ID: 7878295
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypercalcemia in malignancy.
    Strewler GJ; Nissenson RA
    West J Med; 1990 Dec; 153(6):635-40. PubMed ID: 2293469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of the tertiary structure of parathyroid-hormone-related protein (residues 1-34) by the island model.
    Ota M; Saitô N
    J Protein Chem; 1992 Dec; 11(6):623-8. PubMed ID: 1466759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical significance of serum parathyroid hormone-related protein analysis in endocrine tests of the thyroid-parathyroid system].
    Yamaguchi K; Tsuchihashi T; Honda S; Miyake Y; Otsubo K; Nagasaki K
    Nihon Rinsho; 1989 Dec; 48 Suppl():1151-4. PubMed ID: 2621836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.